| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |